Definitive Healthcare (DH) Stock: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$1.15
0.02 (1.77%)
▲
5d:
+16.7%
30d:
+29.21%
90d:
+67.66%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: DH is 12.7% above its trading range ($1.02). Market expects 1.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: DH is 12.7% above its trading range ($1.02). Market expects 1.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $1.15, which is considered extended relative to its 30-day fair value range of $0.93 to $1.02. The stock's valuation (Forward PE: 6.2) is in line with its historical norms (5.9). At these levels, the market is pricing in 1.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DH is in a uptrend. Immediate support is located at $0.96, while resistance sits at $1.21.
Market Sentiment: DH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.90 (+65.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DH is in a uptrend. Immediate support is located at $0.96, while resistance sits at $1.21.
Market Sentiment: DH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.90 (+65.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.93 -
$1.02
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
20.0%
All Signals
- BEARISH: Price significantly overextended (+12.7% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.2% below Wall St target ($1.90)
- NEUTRAL: Market pricing in 1.3% annual earnings growth - fairly valued
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.02
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.96
Resistance Level
$1.21
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.16
Wall Street Target
$1.90
(+65.2%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-72.3%
Valuation Premium vs History
+1.3% premium
PE vs Historical
6.2 vs 5.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$1.16
(+1%)
2-Year Target
$1.18
(+3%)
3-Year Target
$1.20
(+4%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
PE COMPRESSION
$1.14
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -4.2%)
$3.26
(+184%)
Base:
(SPY PE: 6.2, Growth: -4.2%)
$1.01
(-12%)
Bear:
(PE: 5.2, Growth: -4.2%)
$0.86
(-25%)
Share & Embed Analysis
Last updated: October 21, 2026 9:06 PM ET
Data refreshes hourly during market hours. Next update: 10:06 PM
Data refreshes hourly during market hours. Next update: 10:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$297 | 30 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$79 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$34 | 33 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 40 SELL |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$112 | 39 SELL |
